Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs6716290 | chr2:242515096 | A/C | 3.82E-5 | 178 | 25.92 | 25.6 | 20.28 | KM Plot |
PCPG | rs6717283 | chr2:242516105 | A/G | 4.19E-11 | 178 | 25.87 | 24.85 | 10.3 | KM Plot |
PCPG | rs6717829 | chr2:242583729 | G/C | 9.01E-11 | 173 | 25.67 | 25 | 10.3 | KM Plot |
PCPG | rs67182390 | chr2:24284749 | G/GT | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs67211173 | chr2:241538924 | C/G | 3.44E-5 | 178 | 25.92 | 20.2 | 10.3 | KM Plot |
PCPG | rs6721278 | chr2:24359722 | C/T | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs6723592 | chr2:24356526 | A/G | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs67248199 | chr1:54382851 | CAAA/CA | 0.000224 | 174 | 25 | 26.97 | 18.7 | KM Plot |
PCPG | rs67260198 | chr14:74299832 | A/G | 5.08E-6 | 173 | 25.47 | 27.2 | 10.43 | KM Plot |
PCPG | rs672696 | chr1:201679080 | C/G | 1.18E-6 | 178 | 27.2 | 18.75 | 10.3 | KM Plot |
PCPG | rs6729394 | chr2:118551071 | G/A | 1.95E-5 | 176 | 25.17 | 25.53 | 11.65 | KM Plot |
PCPG | rs67324999 | chr3:80548323 | CAGA/C | 6.66E-5 | 176 | 19.87 | 24.03 | 27.2 | KM Plot |
PCPG | rs6733427 | chr2:242587251 | G/A | 7.57E-11 | 175 | 25.67 | 24.7 | 10.3 | KM Plot |
PCPG | rs6736612 | chr2:61536657 | C/A | 6.33E-5 | 178 | 23.77 | 30.33 | 10.3 | KM Plot |
PCPG | rs6736948 | chr2:61536929 | C/T | 6.33E-5 | 178 | 23.77 | 30.33 | 10.3 | KM Plot |